Inflammatory biomarkers and long-term outcome in young patients three months after a first myocardial infarction
Open Access
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Interleukin‐18 in patients with acute coronary syndromesClinical Cardiology, 2019
- The prognostic value of interleukin 6 in multiple chronic diseases and all-cause death: The Multi-Ethnic Study of Atherosclerosis (MESA)Atherosclerosis, 2018
- Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarctionClinical Research in Cardiology, 2018
- C‐reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow‐upClinical Cardiology, 2018
- All roads lead to IL-6: A central hub of cardiometabolic signalingInternational Journal of Cardiology, 2018
- The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: Findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry–Get With the Guidelines (GWTG) Medicare-linked databaseAmerican Heart Journal, 2016
- Gender specific associations between matrix metalloproteinases and inflammatory markers in post myocardial infarction patientsAtherosclerosis, 2009
- Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6Atherosclerosis, 2006
- A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive proteinAtherosclerosis, 2005
- IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failureEuropean Journal of Internal Medicine, 2004